MENU

Fox Chase Cancer Center Earns Reaccreditation From American College of Radiology

June 18, 2021

Dr. Eric M. Horwitz, chair of the Department of Radiation Oncology at Fox Chase.Dr. Eric M. Horwitz, chair of the Department of Radiation Oncology at Fox Chase.

PHILADELPHIA (June 18, 2021)—Fox Chase Cancer Center’s main, Buckingham, and East Norriton campuses have been awarded a three-year term of reaccreditation in radiation oncology as the result of a recent review by the American College of Radiology (ACR).

“The ACR accreditation process is an important national indicator of quality treatment in a radiation oncology department. This is something we take very seriously here at Fox Chase and are very proud of what we do for our patients,” said Eric M. Horwitz, MD, FABS, FASTRO, chair of the Department of Radiation Oncology at Fox Chase.

Radiation oncology, also known as radiation therapy, is the careful use of high-energy radiation to treat cancer. A radiation oncologist may use radiation to treat cancer or to relieve a cancer patient’s pain.

The ACR is a national professional organization serving more than 36,000 diagnostic/interventional radiologists, radiation oncologists, nuclear medicine physicians, and medical physicists with programs focusing on the practice of medical imaging and radiation oncology and the delivery of comprehensive healthcare services.

Dr. Penny R. Anderson, professor in the Department of Radiation Oncology and chief of the Division of Breast and Gynecologic Radiation Oncology at Fox Chase.Dr. Penny R. Anderson, professor in the Department of Radiation Oncology and chief of the Division of Breast and Gynecologic Radiation Oncology at Fox Chase.

“The accreditation process involved a two-day site visit process that was performed by two ACR surveyors, a radiation oncologist and a medical physicist. These two surveyors reviewed numerous patient treatment cases from our main center, as well as our two satellite facilities, Buckingham and East Norriton,” said Penny R. Anderson, MD, professor in the Department of Radiation Oncology and chief of the Division of Breast and Gynecologic Radiation Oncology at Fox Chase. 

“They reviewed the quality and safety of our radiation treatments by analyzing and reviewing our clinical treatment information and our physics treatment information in order to evaluate and determine if we are delivering the highest quality of patient care and patient safety to our radiation oncology patients,” she said.

The ACR is the nation’s oldest and most widely accepted radiation oncology accrediting body, with over 700 accredited sites and 30 years of accreditation experience. The ACR seal of accreditation represents the highest level of quality and patient safety. It is awarded only to facilities meeting specific practice guidelines and technical standards developed by the ACR after a peer-review evaluation by board-certified radiation oncologists and medical physicists who are experts in the field.

Patient care and treatment, patient safety, personnel qualifications, adequacy of facility equipment, quality control procedures, and quality assurance programs are assessed. The findings are reported to the ACR Committee on Radiation Oncology Accreditation, which subsequently provides the practice with a comprehensive report they can use for continuous practice improvement.

“This ACR reaccreditation confirms once again that we continue to deliver high quality radiation treatments for our patients. I want to acknowledge and thank Dr. Penny Anderson and our whole team for the work they did and continue to do to maintain the high standards of care reflected in this accreditation,” said Horwitz.

“Since 2009, our department has been accredited by the ACR, and it is a testament to everyone from the radiation therapists, nurses, dosimetrists, physicists, and physicians that this continues to be the case.”

The Hospital of Fox Chase Cancer Center and its affiliates (collectively “Fox Chase Cancer Center”), a member of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

 

For more information, call 888-369-2427

Connect with Fox Chase